788 results on '"Ghanima, Waleed"'
Search Results
2. Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
3. Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy
4. The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients—a single-arm prospective trial
5. Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study
6. Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
7. Evaluation of the diagnostic performance of three D-dimer assays in patients with suspected deep vein thrombosis: STA-Liatest D-Di plus, Tina-quant D-dimer Gen. 2, and INNOVANCE D-dimer
8. Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
9. The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
10. Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
11. Arterial events in cancer patients treated with apixaban for venous thrombosis
12. A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
13. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
14. SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
15. Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis
16. A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome
17. The venous thrombosis registry in Østfold Hospital (TROLL registry) ‐ design and cohort description
18. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
19. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up
20. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh)
21. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
22. Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia—A nationwide population‐based study
23. Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients
24. Detection of upper extremity deep vein thrombosis by magnetic resonance non‐contrast thrombus imaging
25. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
26. Health‐related quality‐of‐life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
27. Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
28. Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis
29. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
30. Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis
31. Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis.
32. Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism.
33. Risk‐based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP).
34. Safety of using the combination of the Wells rule and D‐dimer test for excluding acute recurrent ipsilateral deep vein thrombosis
35. Risk factors for symptomatic venous thromboembolism following surgery for closed ankle fractures: A case-control study
36. Risk‐based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP)
37. Sustained response off‐treatment in eltrombopag‐treated adult patients with ITP who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase II TAPER trial
38. Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis
39. Risk factors for bleeding in cancer patients treated with conventional dose followed by low dose apixaban for venous thromboembolism
40. Patient outcomes after electrical injury – a retrospective study
41. Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial
42. Gastric sleeve resection as day-case surgery: what affects the discharge time?
43. Updated international consensus report on the investigation and management of primary immune thrombocytopenia
44. Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim
45. Pain and nausea after bariatric surgery with total intravenous anesthesia versus desflurane anesthesia: a double blind, randomized, controlled trial
46. Cardiovascular and bleeding outcomes in a population‐based cohort of patients with chronic immune thrombocytopenia
47. Sustained response off‐treatment in eltrombopag‐treated adult patients with ITP who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase II TAPER trial.
48. Refractory Immune Thrombocytopenia or Myelodysplastic Syndrome Presenting with Isolated Thrombocytopenia? A Review of Literature and a Case Report
49. Rehabilitation to improve exercise capacity and quality of life after pulmonary embolism
50. Objectively measured physical activity and clinical correlates after pulmonary embolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.